Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Standard Biotools (LAB) over the last 12 years, with Q1 2025 value amounting to $139.8 million.

  • Standard Biotools' Goodwill & Intangibles rose 664.79% to $139.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $139.8 million, marking a year-over-year increase of 664.79%. This contributed to the annual value of $140.3 million for FY2024, which is 3020.32% up from last year.
  • As of Q1 2025, Standard Biotools' Goodwill & Intangibles stood at $139.8 million, which was up 664.79% from $140.3 million recorded in Q4 2024.
  • Standard Biotools' Goodwill & Intangibles' 5-year high stood at $143.5 million during Q1 2021, with a 5-year trough of $107.7 million in Q4 2023.
  • In the last 5 years, Standard Biotools' Goodwill & Intangibles had a median value of $130.3 million in 2024 and averaged $127.7 million.
  • In the last 5 years, Standard Biotools' Goodwill & Intangibles soared by 178757.89% in 2021 and then crashed by 1160.75% in 2022.
  • Quarter analysis of 5 years shows Standard Biotools' Goodwill & Intangibles stood at $134.3 million in 2021, then fell by 11.51% to $118.9 million in 2022, then dropped by 9.37% to $107.7 million in 2023, then surged by 30.2% to $140.3 million in 2024, then fell by 0.34% to $139.8 million in 2025.
  • Its last three reported values are $139.8 million in Q1 2025, $140.3 million for Q4 2024, and $129.7 million during Q3 2024.